文献速递肝病

脂滴与代谢功能障碍相关脂肪性肝病病理生理机制偶联的研究

Mechanisms coupling lipid droplets to MASLD pathophysiology.
PubMed 文献 · Hepatology · 2024-10-30

本文综述脂滴生物学在代谢功能障碍相关脂肪性肝病(MASLD)中的作用,指出脂滴从惰性标志物转变为疾病病因的主动参与者,其表面蛋白调控脂质代谢、转运和信号传导,促进代谢功能障碍相关脂肪性肝炎等晚期肝病发展。

要点

  • 脂滴是中性脂质积聚的动态细胞器,参与细胞信号与功能调控。
  • 脂滴表面数百种蛋白调控脂质代谢、转运和信号传导。
  • 脂滴主动促进代谢功能障碍相关脂肪性肝炎等晚期肝病发展。

核心结论

  • 脂滴曾被视为疾病的惰性标志物,现被理解为在疾病病因学中发挥主动作用,并具有重要的非病理性和病理性细胞信号与功能作用,促进晚期肝病包括代谢功能障碍相关脂肪性肝炎的发展。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 肝脂肪变性指中性脂质在脂滴中积聚,在无酒精或病毒感染时通常称为代谢功能障碍相关脂肪性肝病。
  • 代谢功能障碍相关脂肪性肝病包括单纯性脂肪变性和更严重的代谢功能障碍相关脂肪性肝炎,后者以炎症、肝细胞损伤和纤维化为特征。
  • 脂滴的动态特性受覆盖其表面的数百种蛋白紧密调控,这些蛋白控制脂质代谢、转运和信号传导。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatic steatosis, the buildup of neutral lipids in lipid droplets (LDs), is commonly referred to as metabolic dysfunction-associated steatotic liver disease when alcohol or viral infections are not involved. Metabolic dysfunction-associated steatotic liver disease encompasses simple steatosis and the more severe metabolic dysfunction-associated steatohepatitis, characterized by inflammation, hepatocyte injury, and fibrosis. Previously viewed as inert markers of disease, LDs are now understood to play active roles in disease etiology and have significant nonpathological and pathological functions in cell signaling and function. These dynamic properties of LDs are tightly regulated by hundreds of proteins that coat the LD surface, controlling lipid metabolism, trafficking, and signaling. The following review highlights various facets of LD biology with the primary goal of discussing key mechanisms through which LDs promote the development of advanced liver diseases, including metabolic dysfunction-associated steatohepatitis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Reid MV, Fredickson G, Mashek DG, et al. Mechanisms coupling lipid droplets to MASLD pathophysiology. Hepatology. 2024. PMID: 39475114. doi:10.1097/HEP.0000000000001141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。